Trial · NCT03162796
Participant flow27
How many started, completed or left each group, period by period.
1 to 20 of 27
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Placebo Controlled Period: Week 0 - 24 | STARTED | Placebo | 126 | |
| Placebo Controlled Period: Week 0 - 24 | STARTED | Guselkumab 100 mg q8w | 127 | |
| Placebo Controlled Period: Week 0 - 24 | STARTED | Guselkumab 100 mg q4w | 128 | |
| Placebo Controlled Period: Week 0 - 24 | COMPLETED | Placebo | 114 | |
| Placebo Controlled Period: Week 0 - 24 | COMPLETED | Guselkumab 100 mg q8w | 123 | |
| Placebo Controlled Period: Week 0 - 24 | COMPLETED | Guselkumab 100 mg q4w | 125 | |
| Placebo Controlled Period: Week 0 - 24 | NOT COMPLETED | Placebo | 12 | |
| Placebo Controlled Period: Week 0 - 24 | NOT COMPLETED | Guselkumab 100 mg q8w | 4 | |
| Placebo Controlled Period: Week 0 - 24 | NOT COMPLETED | Guselkumab 100 mg q4w | 3 | |
| Active Treatment Period: Week 24 - 52 | STARTED | Placebo | 114 | |
| Active Treatment Period: Week 24 - 52 | STARTED | Guselkumab 100 mg q8w | 123 | |
| Active Treatment Period: Week 24 - 52 | STARTED | Guselkumab 100 mg q4w | 125 | |
| Active Treatment Period: Week 24 - 52 | COMPLETED | Placebo | 107 | |
| Active Treatment Period: Week 24 - 52 | COMPLETED | Guselkumab 100 mg q8w | 116 | |
| Active Treatment Period: Week 24 - 52 | COMPLETED | Guselkumab 100 mg q4w | 124 | |
| Active Treatment Period: Week 24 - 52 | NOT COMPLETED | Placebo | 7 | |
| Active Treatment Period: Week 24 - 52 | NOT COMPLETED | Guselkumab 100 mg q8w | 7 | |
| Active Treatment Period: Week 24 - 52 | NOT COMPLETED | Guselkumab 100 mg q4w | 1 | |
| Safety Follow-up: Week 52 - 60 | STARTED | Placebo | 107 | |
| Safety Follow-up: Week 52 - 60 | STARTED | Guselkumab 100 mg q8w | 116 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03162796/flow